mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
0.16 |
0.0006 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.16 |
0.0006 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0006 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0007 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.001 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.001 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |